IL165897A0 - Drug transport and delivery system - Google Patents

Drug transport and delivery system

Info

Publication number
IL165897A0
IL165897A0 IL16589704A IL16589704A IL165897A0 IL 165897 A0 IL165897 A0 IL 165897A0 IL 16589704 A IL16589704 A IL 16589704A IL 16589704 A IL16589704 A IL 16589704A IL 165897 A0 IL165897 A0 IL 165897A0
Authority
IL
Israel
Prior art keywords
delivery system
drug transport
drug
transport
delivery
Prior art date
Application number
IL16589704A
Other languages
English (en)
Original Assignee
Ghanem Elias Ganem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghanem Elias Ganem filed Critical Ghanem Elias Ganem
Publication of IL165897A0 publication Critical patent/IL165897A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16589704A 2002-06-24 2004-12-21 Drug transport and delivery system IL165897A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02013916 2002-06-24
EP02017756A EP1374907A3 (fr) 2002-06-24 2002-08-09 Système véhiculaire et de délivrance de médicaments
PCT/CH2003/000409 WO2004000365A1 (fr) 2002-06-24 2003-06-23 Systeme de transport et de distribution de medicament

Publications (1)

Publication Number Publication Date
IL165897A0 true IL165897A0 (en) 2006-01-15

Family

ID=29718282

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16589704A IL165897A0 (en) 2002-06-24 2004-12-21 Drug transport and delivery system

Country Status (8)

Country Link
US (1) US20070265212A1 (fr)
EP (1) EP1374907A3 (fr)
JP (1) JP4399601B2 (fr)
CN (1) CN1668336A (fr)
AU (1) AU2003245777B2 (fr)
CA (1) CA2490354A1 (fr)
IL (1) IL165897A0 (fr)
WO (1) WO2004000365A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT506632A1 (de) 2008-04-09 2009-10-15 Apeiron Biolog Forschungs Und Behandlung von tumorerkrankungen
KR20240029316A (ko) * 2022-08-26 2024-03-05 경희대학교 산학협력단 활막 표적화 화합물 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2094175A1 (en) * 1970-06-11 1972-02-04 Istituto Sieroterapic Antitumour oligopeptides - contg meta-(di-(2-chloroethyl)-amino)-l-ph
US3814746A (en) * 1970-08-05 1974-06-04 Inst Sieroterapico Milanese Se Mannich base of tetracycline and polypeptides
US20030162721A1 (en) * 1997-07-07 2003-08-28 Francesco Mehlem Pharmaceutical composition containing peptichemio
US6025328A (en) * 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents
US6767992B1 (en) * 1998-11-19 2004-07-27 Ptc Pharma Ag Method for producing L-prolyl-L-M-sarcolysyl-L-p-fluorophenylalanine and derivatives thereof
SE0002202D0 (sv) * 2000-06-13 2000-06-13 Karolinska Innovations Ab New peptides
CA2411545A1 (fr) * 2000-06-14 2002-01-03 Medarex, Inc. Composes de tripeptide pour promedicaments
US20040009956A1 (en) * 2002-04-29 2004-01-15 Dehua Pei Inhibition of protein tyrosine phosphatases and SH2 domains by a neutral phosphotyrosine mimetic

Also Published As

Publication number Publication date
EP1374907A2 (fr) 2004-01-02
CA2490354A1 (fr) 2003-12-31
JP4399601B2 (ja) 2010-01-20
JP2005537315A (ja) 2005-12-08
AU2003245777B2 (en) 2008-05-22
EP1374907A3 (fr) 2004-01-07
AU2003245777A1 (en) 2004-01-06
CN1668336A (zh) 2005-09-14
US20070265212A1 (en) 2007-11-15
WO2004000365A1 (fr) 2003-12-31

Similar Documents

Publication Publication Date Title
GB0215904D0 (en) Drug delivery system and method
GB2391480B (en) Drug delivery system
PL372323A1 (en) Implantable drug delivery system
HUP0203102A3 (en) Bioadhesive drug delivery system
PL376169A1 (en) Drug delivery system
AU2003286819A8 (en) Alternate delivery location methods and systems
HUP0401438A3 (en) Drug delivery system
SI1631255T1 (sl) Sistem za razdeljevanje zdravil
HK1064920A1 (en) Enhanced drug delivery in transdermal systems
ZA200408199B (en) Probiotic delivery system
AU2003299849A8 (en) Drug delivery apparatus
HK1077523A1 (en) Proliposomal drug delivery system
EP1549380A4 (fr) Systeme et methode d'administration de medicaments
GB2385273B (en) Drug delivery device
EP1667619A4 (fr) Systeme pharmaceutique d'administration
SG118196A1 (en) Content delivery system and content delivery apparatus
AU2003212962A8 (en) Transdermal drug delivery systems
AU2003293361A8 (en) Drug delivery system with vented mouthpiece
EP1539130A4 (fr) Systeme d'administration par voie percutanee et ungueale
IL165897A0 (en) Drug transport and delivery system
AU2003285550A1 (en) Drug delivery system
EP1509612A4 (fr) Systeme de distribution transcellulaire de medicaments
GB2389738B (en) Mail delivery system
IL163614A0 (en) System for transvaginal drug delivery
EP1653953A4 (fr) Procedes et dispositifs pour la delivrance de medicaments